ST.27-legal status data

The legal status information displayed below is based on WIPO Standard ST.27 and of a purely informative nature. Binding information on the status of the IP right is only available in DPMAregister (Show details).

DE file number: 60 2009 045 025.5, EP file number: 13 17 7190.9 (Designation/title: HEMIFUMARATSALZ VON 1-[4-[1-(4-CYCLOHEXYL-3-TRIFLUORMETHYLBENZYLOXYIMINO)-ETHYL]-2-ETHYLBENZYL]AZETIDIN-3-CARBONSÄURE ZUR BEHANDLUNG VON LYMPHOCYTENVERMITTELTEN KRANKHEITEN)

↩ Details

Tabular representation
Current state: Active, Current state: Grant

Key event history
No. Key Event Code Key Event Name Event Date Effective Date Effective Date sorted ascending Publication Date To Stage
1 Q10 Document published Dec 25, 2013Dec 25, 2013 Filing
2 Q10 Document published Feb 6, 2014Feb 6, 2014Feb 6, 2014 Filing
3 Q10 Document published Mar 22, 2017Mar 22, 2017 Examination
4 Q10 Document published May 4, 2017May 4, 2017May 4, 2017 Examination
5 F10 IP right granted Jan 2, 2018Jan 2, 2018Mar 22, 2018 Grant
Detailed event history
No. Detailed Event Code Detailed Event Name Event Date Effective Date Effective Date sorted ascending Publication Date To Stage
1 Q12 Application published Dec 25, 2013Dec 25, 2013 Filing
2 Q10 Document published Feb 6, 2014Feb 6, 2014Feb 6, 2014 Filing
3 Q10 Document published Mar 22, 2017Mar 22, 2017 Examination
4 Q10 Document published May 4, 2017May 4, 2017May 4, 2017 Examination
5 F10 IP right granted Jan 2, 2018Jan 2, 2018Mar 22, 2018 Grant

Graphical representation

Below you will see a simplified graphical representation of the legal status information, which is based on WIPO Standard ST.27 using the "Overall Patent/SPC Prosecution Model" defined therein.

Graphical representation of the ST.27 legal status data